🕵️ Imagenebio, Inc. ($IMA)
SEC insider & ownership activity, last 12 months · CIK 1835579 · every row links its SEC filing
Over the last 12 months insiders sold $17K against $10.6M of open-market buying. Stampacchia Otello bought $8.0M in discretionary trades (Jul). Orbimed Advisors LLC added 6.9% → 13.1%; Orbimed Capital GP VI LLC added 6.7% → 9.6%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $10.6M (7 lots) · 1 seller, $17K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Stampacchia Otello | 1 | $8.0M | 0 | – | Jul 25, 2025 |
| David P. Bonita | 3 | $2.5M | 0 | – | Apr 14, 2026 |
| Joseph P. Slattery | 1 | $96K | 0 | – | Dec 24, 2025 |
| Robert B. Lally | 0 | – | 2 | $17K | Jul 17, 2026 |
| Orbimed Advisors LLC | 2 | – | 0 | – | Apr 14, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 13.1% | 13D | Apr 14, 2026 | filing ↗ | |
| Trails EDGE Capital Partners, LP | 9.9% | 13G | Apr 21, 2026 | filing ↗ | |
| Trails EDGE Biotechnology Master Fund, LP | 9.9% | 13G | Apr 21, 2026 | filing ↗ | |
| Ortav Yehudai | 9.9% | 13G | Apr 21, 2026 | filing ↗ | |
| BVF Partners L P/IL | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| BVF INC/IL | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Mark N. Lampert | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Orbimed Capital GP VI LLC | 9.6% | 13D | Apr 14, 2026 | filing ↗ | |
| BVF GP Holdings LLC | 9.2% | 13G | May 15, 2026 | filing ↗ | |
| Blue OWL Capital Holdings LP | 8.5% | 13G | May 14, 2026 | filing ↗ | |
| Omega Fund VI GP, L.P. | 8.4% | 13D | Apr 14, 2026 | filing ↗ | |
| Omega Fund VI GP Manager, Ltd. | 8.4% | 13D | Apr 14, 2026 | filing ↗ | |
| Claudio Nessi | 8.4% | 13D | Apr 14, 2026 | filing ↗ | |
| Otello Stampacchia | 8.4% | 13D | Apr 14, 2026 | filing ↗ | |
| Omega Fund VI, L.P. | 8.4% | 13D | Apr 14, 2026 | filing ↗ | |
| Leonard Braden Michael | 7.6% | 13G | Dec 31, 2024 | filing ↗ | |
| BML Investment Partners, L.P. | 7.4% | 13G | Dec 31, 2024 | filing ↗ | |
| Funicular Funds, LP | 5.8% | 13G | Jan 6, 2026 | filing ↗ | |
| Cable CAR Capital, LP | 5.8% | 13G | Jan 6, 2026 | filing ↗ | |
| Ma-Weaver Jacob | 5.8% | 13G | Jan 6, 2026 | filing ↗ | |
| Biotechnology Value Fund L P | 5.3% | 13G | May 15, 2026 | filing ↗ | |
| BVF I GP LLC | 5.3% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 20, 2026 | filing ↗ |
| Other events (8.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 16, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 12, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 12, 2026 | filing ↗ |
| Earnings (2.02) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 19, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 1, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 23, 2025 | filing ↗ |
| Agreement terminated (1.02) | Oct 23, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 21, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 10, 2025 | filing ↗ |
| Auditor change (4.01) | Aug 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 2, 2025 | filing ↗ |
| Officer/director changes (5.02) | Jul 28, 2025 | filing ↗ |
| Other events (8.01) | Jul 28, 2025 | filing ↗ |